|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0014939,
umls-concept:C0024202,
umls-concept:C0031809,
umls-concept:C0034897,
umls-concept:C0205547,
umls-concept:C0220825,
umls-concept:C0279781,
umls-concept:C0441766,
umls-concept:C0449820,
umls-concept:C0681842,
umls-concept:C0853879,
umls-concept:C1521733,
umls-concept:C1709318,
umls-concept:C2348519
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2010-11-3
|
|
pubmed:abstractText |
Oncotype DX is a multigene reverse transcription-polymerase chain reaction assay used to quantify recurrence risk in patients with stage I or II estrogen receptor-positive, lymph node-negative invasive breast cancer. The results are reported as a Recurrence Score (RS). The 16 cancer genes evaluated include a proliferation set, hormone receptor set, and HER2 set. The activity of these genes is addressed by pathologic assessment of breast cancers.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1543-2165
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
134
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1697-701
|
|
pubmed:meshHeading |
pubmed-meshheading:21043825-Adult,
pubmed-meshheading:21043825-Aged,
pubmed-meshheading:21043825-Aged, 80 and over,
pubmed-meshheading:21043825-Breast Neoplasms,
pubmed-meshheading:21043825-Carcinoma, Ductal, Breast,
pubmed-meshheading:21043825-Cell Proliferation,
pubmed-meshheading:21043825-Estrogen Receptor alpha,
pubmed-meshheading:21043825-Female,
pubmed-meshheading:21043825-Gene Expression Profiling,
pubmed-meshheading:21043825-Humans,
pubmed-meshheading:21043825-Middle Aged,
pubmed-meshheading:21043825-Multivariate Analysis,
pubmed-meshheading:21043825-Neoplasm Recurrence, Local,
pubmed-meshheading:21043825-Neoplasm Staging,
pubmed-meshheading:21043825-Predictive Value of Tests,
pubmed-meshheading:21043825-Prognosis,
pubmed-meshheading:21043825-Receptors, Progesterone,
pubmed-meshheading:21043825-Reverse Transcriptase Polymerase Chain Reaction
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Can features evaluated in the routine pathologic assessment of lymph node-negative estrogen receptor-positive stage I or II invasive breast cancer be used to predict the Oncotype DX recurrence score?
|
|
pubmed:affiliation |
Department of Pathology, Montefiore Medical Center, Bronx, NY, USA.
|
|
pubmed:publicationType |
Journal Article
|
